Ping Gao

Oulu, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

LncRNA AC021683.2 promotes chemotherapy resistance in acute myeloid leukemia.

LncRNA AC021683.2 promotes chemotherapy resistance in acute myeloid leukemia.

Journal: iScience

Published: October 30, 2024

TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunity.

TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunity.

Journal: Oncogene

Published: September 23, 2024

VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis.

VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis.

Journal: Nature communications

Published: June 06, 2024

PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer.

PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer.

Journal: Oncogene

Published: September 07, 2021

Large Multicohort Study Reveals a Prostate Cancer Susceptibility Allele at 5p15 Regulating TERT via Androgen Signaling-Orchestrated Chromatin Binding of E2F1 and MYC.

Large Multicohort Study Reveals a Prostate Cancer Susceptibility Allele at 5p15 Regulating TERT via Androgen Signaling-Orchestrated Chromatin Binding of E2F1 and MYC.

Journal: Frontiers in oncology

Published: August 06, 2021

Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer.

Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 06, 2018

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Journal: Cell

Published: October 11, 2017

High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.

High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing.

Journal: Nature communications

Published: August 24, 2017

A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer.

A Large-Scale, Exome-Wide Association Study of Han Chinese Women Identifies Three Novel Loci Predisposing to Breast Cancer.

Journal: Cancer research

Published: June 14, 2017

Genomic Insight into the Role of lncRNA in Cancer Susceptibility.

Genomic Insight into the Role of lncRNA in Cancer Susceptibility.

Journal: International journal of molecular sciences

Published: May 23, 2017

Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT.

Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT.

Journal: Oncogene

Published: November 24, 2016

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.

Journal: Scientific reports

Published: November 11, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026